Search Results

You searched for : nonsmall  

Roche’s Tecentriq approved by European Commission for metastatic non-small cell lung cancer

Tecentriq is now the first and only single-agent cancer immunotherapy with three dosing options...
May 08

Imfinzi recommended for approval in the EU by CHMP for non-small cell lung cancer

This new dosing option is consistent with the approved Imfinzi dosing in extensive-stage small cell lung cancer and once approved, will be available to ...
Dec 15

FDA grants priority review of Regeneron-Sanofi's Libtayo for advanced Non-small Cell Lung Cancer

Libtayo is indicated for advanced non-smal cell cancer with PD-L1 Expression of ≥50%...
Oct 31

Roche receives US FDA approval for the cobas EGFR mutation test v2

Roche receives FDA approval for the cobas EGFR mutation test v2 as the first companion diagnostic test for expanded EGFR TKI therapies in patients with ...
Oct 30

Roche announces FDA approval of Gavreto (pralsetinib) for the treatment of lungs cancer

Gavreto is used in treatment of adults with metastatic RET fusion-positive non-small cell lung cancer...
Sep 08

PharmAbcine signs a CMO contract with Binex for Olinvacimab production

Binex will produce olinvacimab at its new 5,000L production line...
Sep 03

Thermo Fisher and Daiichi Sankyo joins hands : Non small cell cancer

Two pharma giants come together for developing Global Companion Diagnostics for patients with NSCLC cancer...
Jun 25

Three-Year Survival Update: Pembrolizumab Effective as First-Line Therapy for Advanced Non-Small Cell Lung Cancer

First-line pembrolizumab monotherapy provides durable long-term overall survival benefit compared to chemotherapy, according to data presented today by Dr. M. Reck, Lung Clinic ...
Sep 10

8 Matching result(s) found!


Trending Now

We have more infection-prevention options now but are they actual choices for the people?July 19, 2024
New humidity-driven membrane to remove carbon dioxide from the airJuly 19, 2024
Introducing the World's First Consent-Based Data-Sharing Framework Built on Open Standards: The Affinidi Iota Framework July 19, 2024
The Power of Green Spaces: Evidence That Parks May Delay Cognitive DeclineJuly 19, 2024
Strengthening Healthcare in India: The Push for Better Coverage with Ayushman BharatJuly 19, 2024
SARV Events & Celebrations Shines at "Edu-Bizz Leadership Summit & Awards 24July 18, 2024
UAE launches global initiative to build 10 hospitals to address critical healthcare gaps as part of Zayed Humanitarian Legacy InitiativeJuly 18, 2024
Geetanjali Homestate Expands Global Presence with the Launch of Geetanjali GlobalJuly 18, 2024
Changes projected in marine fish communities due to climate changeJuly 18, 2024
Understanding the Chandipura Virus Outbreak in Gujarat: A Critical OverviewJuly 18, 2024
Landmark Study Links Severe Endometriosis to Increased Risk of Ovarian CancerJuly 18, 2024
Equipping Healthcare Professionals for Global Opportunities: GIMS Partners with NSDCJuly 18, 2024
Hormone Modulating Therapy for Breast Cancer and Its Link to Lower Alzheimer’s RiskJuly 18, 2024
Multipl Secures $1.5 Million in Additional Funds, Led by Blume Ventures and MIXI Global Investments, JapanJuly 17, 2024
FedEx to empower youth with digital skilling programJuly 17, 2024
Putting people first means following Gandhi's TalismanJuly 17, 2024
American Oncology Institute (AOI) Launches #BreaktheHabit Campaign to Raise Awareness on Head & Neck cancerJuly 17, 2024
Chamraj Tea Estate Launches New Nilgiri Tea Blends: ‘Master Blend,’ ‘Master Blend Ginger Tea,’ and ‘Master Blend Lemon Tea’July 16, 2024
How a Fiber-Rich Diet and Gut Parasites Can Improve Your HealthJuly 16, 2024
LinkedIn: A Double-Edged Sword for Professional GrowthJuly 16, 2024